P. Roy and Diana T. Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 S 34th St., Philadelphia, Pennsylvania 19104, United States.
Eramet Ideas, 1 avenue Albert Einstein, 78190 Trappes, France.
Inorg Chem. 2023 Apr 17;62(15):6155-6168. doi: 10.1021/acs.inorgchem.3c00375. Epub 2023 Apr 5.
A series of thorium anilide compounds [ThNHAr(TriNOx)] (R = -OCH (), -H (), -Cl (), -CF (), TriNOx = (2--butylhydroxylaminato)benzylamine), and their corresponding imido compounds [Li(DME)][Th═NAr(TriNOx)] () as well as the alkyl congeners [ThNHAd(TriNOx)] () and [Li(DME)][Th═NAd(TriNOx)] (), have been prepared. The -substituents on the arylimido moiety were introduced for systematic variation of their electron-donating and withdrawing abilities, changes that were evident in measurements of the C{H} NMR chemical shifts of the -C atom of the Ar moiety. Room temperature, solution-state luminescence of the four new thorium imido compounds, along with the previously reported [Li(THF)][Th═NAr(TriNOx)] () and [Li(THF)(EtO)][Ce═NAr(TriNOx)] () have been described. Among these complexes, demonstrated the most intense luminescence feature with excitation at 398 nm and emission at 453 nm. The luminescence measurements, together with a time-dependent density functional theory (TD-DFT) study, helped uncover an intra-ligand n → π* transition that was assigned as the origin of the bright blue luminescence; has an 1.2 eV redshift in excitation energy compared with its proligand. The weak luminescence of other derivatives ( and ) was attributed to non-radiative decay from low-lying excited states originating from inter-ligand transitions () or ligand-to-metal charge transfer bands (). Overall, the results expand the range of the thorium imido organometallic compounds and demonstrate that thorium(IV) complexes can support strong ligand luminescence. The results also demonstrate the utility of applying a Th(IV) center for tuning the n → π* luminescence energy and intensity of an associated imido moiety.
一系列钍苯胺化合物 [ThNHAr(TriNOx)](R = -OCH(),-H(),-Cl(),-CF(),TriNOx = (2--丁基羟氨基)苄胺),以及它们相应的亚胺化合物 [Li(DME)][Th═NAr(TriNOx)] (),以及烷基同类物 [ThNHAd(TriNOx)] ()和 [Li(DME)][Th═NAd(TriNOx)] (),已经制备。芳基亚胺部分的 -取代基用于系统地改变其供电子和吸电子能力,这在 Ar 部分的 -C 原子的 C{H}NMR 化学位移测量中显而易见。描述了四个新的钍亚胺化合物以及先前报道的 [Li(THF)][Th═NAr(TriNOx)] ()和 [Li(THF)(EtO)][Ce═NAr(TriNOx)] ()的室温溶液态发光。在这些配合物中, 表现出最强烈的发光特征,在 398nm 激发时发射 453nm。发光测量结果与时间相关密度泛函理论(TD-DFT)研究一起,有助于揭示一个配体内 n → π跃迁,该跃迁被认为是明亮蓝色发光的起源;与前体相比, 的激发能有 1.2eV 的红移。其他衍生物( 和 )的弱发光归因于来自配体间跃迁()或配体到金属电荷转移带()的低能激发态的非辐射衰减。总体而言,结果扩展了钍亚胺有机金属化合物的范围,并证明了四价钍配合物可以支持强配体发光。结果还表明,应用 Th(IV) 中心来调节相关亚胺部分的 n → π发光能量和强度是有用的。